RAPID - Phase III

Principal Investigators

Misti Malone, PhD, U.S. FDA

Melanie Raska, Boston Scientific

Daniel Bertges, MD Society for Vascular Surgery (SVS), Vascular Quality Initiative (VQI)

RAPID Phase III- Pathways Mission

  • Provide a pre-competitive, neutral ground in which to convene and facilitate collaboration among multiple independent stakeholders that have interest in peripheral arterial disease (PAD) device evaluation 

  • Support the safe, efficient and informed prospective use and evaluation of PAD devices in clinical practice and clinical trials throughout their lifecycle 

  • Promote and utilize coordinated PAD registry networks in the assessment of PAD devices 

  • Facilitate the alignment of strategies, analytics and reporting in order to achieve a more expeditious and informative signal discernment of PAD devices including drug eluting technologies 

  • Promote principles of leaner and more efficient prospective and retrospective device safety/benefit PAD device evaluation and potentially generalizable beyond PAD devices in alignment with RAPID’s designation as a NESTcc Demonstration Programs

Completed Phase III Work Products

  • Patient Science 101 Webinar

Working Groups

Contact Us